Icatibant
- PDF / 169,084 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 81 Downloads / 145 Views
1 S
Gastritis, reflux oesophagitis and angioedema crisis: 2 case reports In an observational study conducted between July 2009 and 28 February 2018 involving 574 patients, 2 young patients [sexes and exact ages not stated] were described, of whom one patient developed gastritis and reflux oesophagitis, and the other patient developed angioedema crisis during treatment with icatibant for hereditary angioedema [route, dosage, duration of treatment to reaction onsets and outcomes not stated]. The patients, who had hereditary angioedema with C1 inhibitor deficiency (C1-INH-HAE), started receiving treatment with icatibant. Subsequently, one of the two patients developed gastritis and reflux oesophagitis, and the other patient developed angioedema crisis. Botha J, et al. Elderly versus younger patients with hereditary angioedema type I/II: Patient characteristics and safety analysis from the Icatibant Outcome Survey. Clinical and 803508210 Translational Allergy 9: 37, No. 1, 19 Jul 2019. Available from: URL: http://doi.org/10.1186/s13601-019-0272-9
0114-9954/20/1826-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 17 Oct 2020 No. 1826
Data Loading...
